期刊
ONCOTARGETS AND THERAPY
卷 8, 期 -, 页码 3585-3593出版社
DOVE MEDICAL PRESS LTD
DOI: 10.2147/OTT.S92832
关键词
15-deoxy-Delta(12,14)-prostaglandin J(2); hepatoma cell; ROS; apoptosis; JNK
资金
- National Natural Science Foundation of China [81270515]
Objective: 15-Deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) induces reactive oxygen species (ROS)-mediated apoptosis in many malignant cells, which has not been studied in hepatoma cells. In this study, we investigated whether 15d-PGJ(2) induced apoptosis in hepatocellular carcinoma (HCC) associated with ROS. Materials and methods: The LM3, SMMC-7721, and Huh-7 HCC cell lines were treated with 15d-PGJ(2) (5-40 mu M) for 24, 48, and 72 hours. Cholecystokinin 8 was used to detect the cytotoxicity of 15d-PGJ(2). Flow cytometry, Hoechst staining, and Western blotting were used to analyze apoptosis. ROS were combined with the fluorescent probe dihydroethidium and then observed by fluorescence microscopy and flow cytometry. Activation of JNK and expression of Akt were detected by Western blotting. Results: 15d-PGJ(2) inhibited HCC cell proliferation and induced apoptosis in a dose-and time-dependent manner. Apoptosis was mainly induced via an intrinsic pathway and was ROS-dependent, and was alleviated by ROS scavengers. ROS induced JNK activation and Akt downregulation in HCC cells. Conclusion: 15d-PGJ(2) induced ROS in HCC cell lines, and inhibition of cell growth and apoptosis were partly ROS-dependent.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据